Merck Sues Sandoz Over Plan For Generic Emend
Merck & Co. Inc. has sued Sandoz Inc., Novartis Pharmaceutical Corp.'s generics unit, over its plan to make a generic version of the anti-nausea drug Emend, alleging that the generic drug...To view the full article, register now.
Already a subscriber? Click here to view full article